Please assess the completion status of the following clinical trial:

Trial Title: Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ambulatory critical limb ischemia (Rutherford Score 4/5)~* Not optimal for surgical or catheter-based revascularization~* Obstructive atherosclerosis of at least 1 major artery in both limbs~* Ankle-Brachial Index \<0.6 or Absolute Ankle pressure \<60mmHg or toe pressure \<40mmHg or pulse volume recording that is flat or barely pulsatile~Exclusion Criteria:~* Gangrene(Rutherford 6) or pre-existing major tissue loss~* Unstable Angina, MI, stroke, CHF (class III or IV) within 6 months of study treatment

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Autologous Stem cells (CD133+) (Type: ACTIVE_COMPARATOR): Intramuscular injection
- Control (Type: PLACEBO_COMPARATOR): Intramuscular Injection

Based on this trial design, predict the completion outcome and termination type (if applicable).